Anti-Semaphorin-7A single chain antibody demonstrates beneficial effects on pulmonary inflammation during acute lung injury Retraction in /10.3892/etm.2023.12165

Chen,Xiao; Wang,Hailing; Jia,Kui; Wang,Hao; Ren,Tao

doi:10.3892/etm.2018.5724

Anti-Semaphorin-7A single chain antibody demonstrates beneficial effects on pulmonary inflammation during acute lung injury

Retraction in: /10.3892/etm.2023.12165

Authors:
- Xiao Chen
- Hailing Wang
- Kui Jia
- Hao Wang
- Tao Ren
View Affiliations

Affiliations: Department of ICU, The First Affiliated Hospital, Nanyang Medicine College, Nanyang, Henan 473058, P.R. China
Published online on: January 8, 2018 https://doi.org/10.3892/etm.2018.5724
Pages: 2356-2364
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pulmonary inflammation is a primary characteristic of lung injury initiated by the accession of immune cells into the alveolar space. Neutrophil migration serves an important role in pulmonary inflammation mediated by the migration of neutrophils into hypoxic tissue sites. The elimination of pulmonary inflammation is directly associated with rehabilitation in patients with lung injury. Anti‑inflammatory treatment is essential following lung injury and ultimately determines patient outcomes. Semaphorin‑7A (SEMA‑7A) is a member of the Semaphorin family that influences the migration of neutrophils into hypoxic tissue sites, thus promoting inflammation. However, understanding of the role of SEMA‑7A serves during lung injury is limited and the immunological function of SEMA‑7A during the migration of neutrophils into acute injury sites remains unknown. The present study investigated SEMA‑7A expression and constructed a single chain antibody for SEMA‑7A (Anti‑SEMA‑7A) to study its therapeutic efficacy against pulmonary inflammation in a mouse model of acute injury sites. The data indicated that the expression of SEMA‑7A was upregulated due to induction by pro‑inflammatory cytokines and demonstrated that Anti‑SEMA‑7A inhibited SEMA‑7A expression in vitro and in vivo. The current study also indicated that the production of pro‑inflammatory cytokines induced by SEMA‑7A in endothelial and epithelial cells enhanced pulmonary inflammation. Anti‑SEMA‑7A suppressed the transendothelial migration of neutrophils mediated by SEMA‑7A. Anti‑SEMA‑7A treatment neutralized SEMA‑7A expression and reduced signs of pulmonary inflammation, leading to the elimination of pulmonary inflammation in rat with acute lung injury. The current study identified Anti‑SEMA‑7A as a potential agent to interfere with the inflammatory pathway during acute lung injury, which may be the basis for anti-inflammatory strategies to treat lung injuries in the future.

View Figures

View References

1	Iwata K, Doi A, Ohji G, Oka H, Oba Y, Takimoto K, Igarashi W, Gremillion DH and Shimada T: Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): A systematic review and meta-analysis. Intern Med. 49:2423–2432. 2010. View Article : Google Scholar : PubMed/NCBI
2	Schmickl CN, Mastrobuoni S, Filippidis FT, Shah S, Radic J, Murad MH, Toy P and Gajic O: Male-predominant plasma transfusion strategy for preventing transfusion-related acute lung injury: A systematic review. Crit Care Med. 43:205–225. 2015. View Article : Google Scholar : PubMed/NCBI
3	Kim J, Song J and Lee M: Combinational delivery of HMGB1 A box and heparin for acute lung injury. J Control Release. 213:e572015. View Article : Google Scholar : PubMed/NCBI
4	Butt Y, Kurdowska A and Allen TC: Acute lung injury: A clinical and molecular review. Arch Pathol Lab Med. 140:345–350. 2016. View Article : Google Scholar : PubMed/NCBI
5	Hirano Y, Aziz M, Yang WL, Ochani M and Wang P: Neutralization of osteopontin ameliorates acute lung injury induced by intestinal ischemia-reperfusion. Shock. 46:431–438. 2016. View Article : Google Scholar : PubMed/NCBI
6	Braun RK, Koch JM, Hacker TA, Pegelow D, Kim J, Raval AN, Schmuck EG, Schwahn DJ, Hei DJ, Centanni JM, et al: Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion. Cytotherapy. 18:536–545. 2016. View Article : Google Scholar : PubMed/NCBI
7	McIntyre LA, Moher D, Fergusson DA, Sullivan KJ, Mei SH, Lalu M, Marshall J, Mcleod M, Griffin G, Grimshaw J, et al: Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: A Systematic review. PLoS One. 11:e01471702016. View Article : Google Scholar : PubMed/NCBI
8	Eves ND, Song Y, Piper A and Maher TM: Year in review 2012: Acute lung injury, interstitial lung diseases, sleep and physiology. Respirology. 18:555–564. 2013. View Article : Google Scholar : PubMed/NCBI
9	Cermáková Z, Simetka O and Kořístka M: Transfusion-related acute lung injury (TRALI)-review. Ceska Gynekol. 78:211–215. 2013.(In Czech). PubMed/NCBI
10	Dzierba AL, Abel EE, Buckley MS and Lat I: A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome. Pharmacotherapy. 34:279–290. 2014. View Article : Google Scholar : PubMed/NCBI
11	Vlaar AP and Juffermans NP: Transfusion-related acute lung injury: A clinical review. Lancet. 382:984–994. 2013. View Article : Google Scholar : PubMed/NCBI
12	Sud S, Sud M, Friedrich JO, Meade MO, Ferguson ND, Wunsch H and Adhikari NK: High frequency oscillation in patients with acute lung injury and acute respiratory distress syndrome (ARDS): Systematic review and meta-analysis. BMJ. 340:c23272010. View Article : Google Scholar : PubMed/NCBI
13	Jaswal DS, Leung JM, Sun J, Cui X, Li Y, Kern S, Welsh J, Natanson C and Eichacker PQ: Tidal volume and plateau pressure use for acute lung injury from 2000 to present: A systematic literature review. Crit Care Med. 42:2278–2289. 2014. View Article : Google Scholar : PubMed/NCBI
14	Zhang M, Wang L, Dong M, Li Z and Jin F: Endothelial Semaphorin 7A promotes inflammation in seawater aspiration-induced acute lung injury. Int J Mol Sci. 15:19650–19661. 2014. View Article : Google Scholar : PubMed/NCBI
15	Holmes S, Downs AM, Fosberry A, Hayes PD, Michalovich D, Murdoch P, Moores K, Fox J, Deen K, Pettman G, et al: Sema7A is a potent monocyte stimulator. Scand J Immunol. 56:270–275. 2002. View Article : Google Scholar : PubMed/NCBI
16	Roth JM, Köhler D, Schneider M, Granja TF and Rosenberger P: Semaphorin 7A aggravates pulmonary inflammation during lung injury. PLoS One. 11:e01469302016. View Article : Google Scholar : PubMed/NCBI
17	Wu H, Yao L, Chou L, Yang JH, Zhang YX, Li XL and Shan BE: Construction and functional analysis of an anti-human cervical carcinoma/anti-human CD3 single-chain bispecific antibody. Mol Med Rep. 14:804–810. 2016. View Article : Google Scholar : PubMed/NCBI
18	Singh PK, Agrawal R, Kamboj DV and Singh L: Construction of recombinant single chain variable fragment (ScFv) antibody against superantigen for immunodetection using antibody phage display technology. Methods Mol Biol. 1396:207–225. 2016. View Article : Google Scholar : PubMed/NCBI
19	Pasello M, Zamboni S, Mallano A, Flego M, Picci P, Cianfriglia M and Scotlandi K: Design and construction of a new human naive single-chain fragment variable antibody library, IORISS1. J Biotechnol. 224:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
20	Bjarnadottir SG and Flengsrud R: Affinity chromatography, two-dimensional electrophoresis, adapted immunodepletion and mass spectrometry used for detection of porcine and piscine heparin-binding human plasma proteins. J Chromatogr B Analyt Technol Biomed Life Sci. 944:107–113. 2014. View Article : Google Scholar : PubMed/NCBI
21	London AS, Mackay K, Lihon M, He Y and Alabi BR: Gel filtration chromatography as a method for removing bacterial endotoxin from antibody preparations. Biotechnol Prog. 30:1497–1501. 2014. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Rauch S, Johannes A, Zollhofer B and Muellenbach RM: Evaluating intra-abdominal pressures in a porcine model of acute lung injury by using a wireless motility capsule. Med Sci Monit. 18:BR163–BR166. 2012. View Article : Google Scholar : PubMed/NCBI
24	Yang L, Wu X, Liu F, Duan Y and Li S: Novel biodegradable polylactide/poly(ethylene glycol) mice lles prepared by direct dissolution method for controlled delivery of anticancer drugs. Pharm Res. 26:2332–2342. 2009. View Article : Google Scholar : PubMed/NCBI
25	Gutierrez-Franco A, Costa C, Eixarch H, Castillo M, Medina-Rodríguez EM, Bribián A, de Castro F, Montalban X and Espejo C: Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design. Clin Immunol. 163:22–33. 2016. View Article : Google Scholar : PubMed/NCBI
26	Allegra M, Zaragkoulias A, Vorgia E, Ioannou M, Litos G, Beug H and Mavrothalassitis G: Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells. Mol Biol Cell. 23:3873–3881. 2012. View Article : Google Scholar : PubMed/NCBI
27	Jeon CM, Shin IS, Shin NR, Hong JM, Kwon OK, Kim JH, Oh SR, Bach TT, Hai DV, Quang BH, et al: Clausena anisata-mediated protection against lipopolysaccharide-induced acute lung injury in mice. Int J Mol Med. 37:1091–1098. 2016. View Article : Google Scholar : PubMed/NCBI
28	Bianchi AM, Reboredo MM, Lucinda LM, Reis FF, Silva MV, Rabelo MA, Holanda MA, Oliveira JC, Lorente JÁ and Pinheiro Bdo V: The Effects of Prone position ventilation on experimental mild acute lung injury induced by intraperitoneal lipopolysaccharide injection in rats. Lung. 194:193–199. 2016. View Article : Google Scholar : PubMed/NCBI
29	Ariza-Prota M, Pando-Sandoval A and Garcia-Clemente M: Lung injury caused by all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Arch Bronconeumol. 52:441–442. 2016. View Article : Google Scholar : PubMed/NCBI
30	Piper A, Song Y, Eves ND and Maher TM: Year in review 2013: Acute lung injury, interstitial lung diseases, sleep and physiology. Respirology. 19:428–437. 2014. View Article : Google Scholar : PubMed/NCBI
31	McMullen SM, Meade M, Rose L, Burns K, Mehta S, Doyle R and Henzler D; Canadian Critical Care Trials Group (CCCTG), : Partial ventilatory support modalities in acute lung injury and acute respiratory distress syndrome-a systematic review. PLoS One. 7:e401902012. View Article : Google Scholar : PubMed/NCBI
32	Osaka D, Shibata Y, Kanouchi K, Nishiwaki M, Kimura T, Kishi H, Abe S, Inoue S, Tokairin Y, Igarashi A, et al: Soluble endothelial selectin in acute lung injury complicated by severe pneumonia. Int J Med Sci. 8:302–308. 2011. View Article : Google Scholar : PubMed/NCBI
33	Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R, Miyasho T, Takamiya R, Asano K, Ishizaka A, et al: The anti-inflammatory and proresolving mediator resolvin E1 protects rat from bacterial pneumonia and acute lung injury. J Immunol. 184:836–843. 2010. View Article : Google Scholar : PubMed/NCBI
34	Nieuwenhuizen L, de Groot PG, Grutters JC and Biesma DH: A review of pulmonary coagulopathy in acute lung injury, acute respiratory distress syndrome and pneumonia. Eur J Haematol. 82:413–425. 2009. View Article : Google Scholar : PubMed/NCBI
35	Nakamura S, Yanagihara K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Mukae H, Tashiro T and Kohno S: Efficacy of sivelestat for acute lung injury due to severe bacterial pneumonia with systemic inflammatory response syndrome. Nihon Kokyuki Gakkai Zasshi. 46:793–797. 2008.(In Japanese). PubMed/NCBI
36	Czopik AK, Bynoe MS, Palm N, Raine CS and Medzhitov R: Semaphorin 7A is a negative regulator of T cell responses. Immunity. 24:591–600. 2006. View Article : Google Scholar : PubMed/NCBI
37	Garcia-Gonzalez MJ, Dominguez-Rodriguez A and Ferrer-Hita JJ: Unusual etiology of acute lung injury in a patient with acute myocardial infarction. Int J Cardiol. 117:e95–e97. 2007. View Article : Google Scholar : PubMed/NCBI
38	Delorme G, Saltel F, Bonnelye E, Jurdic P and Machuca-Gayet I: Expression and function of semaphorin 7A in bone cells. Biol Cell. 97:589–597. 2005. View Article : Google Scholar : PubMed/NCBI
39	Morote-Garcia JC, Napiwotzky D, Köhler D and Rosenberger P: Endothelial Semaphorin 7A promotes neutrophil migration during hypoxia. Proc Natl Acad Sci USA. 109:pp. 14146–14151. 2012; View Article : Google Scholar : PubMed/NCBI
40	Zarbock A, Bishop J, Muller H, Schmolke M, Buschmann K, Van Aken H and Singbartl K: Chemokine homeostasis vs. chemokine presentation during severe acute lung injury: the other side of the Duffy antigen receptor for chemokines. Am J Physiol Lung Cell Mol Physiol. 298:L462–L471. 2010. View Article : Google Scholar : PubMed/NCBI
41	Bhatia M, Zemans RL and Jeyaseelan S: Role of chemokines in the pathogenesis of acute lung injury. Am J Respir Cell Mol Biol. 46:566–572. 2012. View Article : Google Scholar : PubMed/NCBI
42	Allegra M, Zaragkoulias A, Vorgia E, Ioannou M, Litos G, Beug H and Mavrothalassitis G: Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells. Mol Biol Cell. 23:3873–3881. 2012. View Article : Google Scholar : PubMed/NCBI
43	Kojicic M, Li G, Hanson AC, Lee KM, Thakur L, Vedre J, Ahmed A, Baddour LM, Ryu JH and Gajic O: Risk factors for the development of acute lung injury in patients with infectious pneumonia. Crit Care. 16:R462012. View Article : Google Scholar : PubMed/NCBI